These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34027585)

  • 21. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
    Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectability.
    Jang JK; Choi SJ; Byun JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Hwang DW; Kim SC
    J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1025-1034. PubMed ID: 35658103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysis.
    Teske C; Stimpel R; Distler M; Merkel S; Grützmann R; Bolm L; Wellner U; Keck T; Aust DE; Weitz J; Welsch T
    Langenbecks Arch Surg; 2021 Aug; 406(5):1481-1489. PubMed ID: 33712875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    J Surg Res; 2021 Jan; 257():605-615. PubMed ID: 32947122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
    Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
    Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival.
    Tjaden C; Hinz U; Klaiber U; Heger U; Springfeld C; Goeppert B; Schmidt T; Mehrabi A; Strobel O; Berchtold C; Schneider M; Diener M; Neoptolemos JP; Hackert T; Büchler MW
    Ann Surg; 2023 Jan; 277(1):e112-e118. PubMed ID: 34171863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of positive histological margins in patients with pancreatic head ductal adenocarcinoma and lymph node involvement: an international multicentric study.
    Joliat GR; Allemann P; Labgaa I; Sulzer J; Vrochides D; Zerbi A; Nappo G; Perinel J; Adham M; Nentwich MF; Izbicki JR; Demartines N; Schäfer M
    HPB (Oxford); 2021 Mar; 23(3):379-386. PubMed ID: 32782224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter?
    Drake JA; Stiles ZE; Behrman SW; Glazer ES; Deneve JL; Somer BG; Vanderwalde NA; Dickson PV
    HPB (Oxford); 2020 Nov; 22(11):1530-1541. PubMed ID: 32209323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data.
    Giovinazzo F; Soggiu F; Jang JY; Versteijne E; van Tienhoven G; van Eijck CH; Han Y; Choi SH; Kang CM; Zalupski M; Ahmad H; Yentz S; Helton S; Rose JB; Takishita C; Nagakawa Y; Abu Hilal M
    Front Oncol; 2020; 10():1112. PubMed ID: 32850319
    [No Abstract]   [Full Text] [Related]  

  • 31. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
    Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
    Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.
    Ivey GD; Shoucair S; Delitto DJ; Habib JR; Kinny-Köster B; Shubert CR; Lafaro KJ; Cameron JL; Burns WR; Burkhart RA; Thompson EL; Narang A; Zheng L; Wolfgang CL; He J
    World J Surg; 2022 Nov; 46(11):2751-2759. PubMed ID: 35861852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?
    Guo Y; Czeyda-Pommersheim F; Miccio JA; Mahalingam S; Cecchini M; Pahade J
    Abdom Radiol (NY); 2021 Dec; 46(12):5609-5617. PubMed ID: 34557934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?
    Lad NL; Squires MH; Maithel SK; Fisher SB; Mehta VV; Cardona K; Russell MC; Staley CA; Adsay NV; Kooby DA
    Ann Surg Oncol; 2013 Oct; 20(11):3626-33. PubMed ID: 23838908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first.
    Tong YT; Wang H; Wei D; Prakash LR; Kim M; Tzeng CD; Lee JE; Rashid A; Koay EJ; Wolff RA; Maitra A; Katz MH; Wang H
    Pancreatology; 2021 Oct; 21(7):1378-1385. PubMed ID: 34429247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Pawlik TM; Weber SM; Poultsides G; Schmidt C; Votanopoulos K; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Jin LX; Levine E; Cho CS; Bloomston M; Winslow E; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2014 Dec; 21(13):4202-10. PubMed ID: 25047464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
    Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal Management of Resectable Pancreatic Head Cancer in the Elderly Patient: Does Neoadjuvant Therapy Offer a Survival Benefit?
    Rieser CJ; Zenati M; Narayanan S; Bahary N; Lee KK; Paniccia A; Bartlett DL; Zureikat AH
    Ann Surg Oncol; 2021 Oct; 28(11):6264-6272. PubMed ID: 33748894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.